Prevail Therapeutics

Prevail Therapeutics, Inc. is developing a series of gene therapies to treat Parkinson's disease and other neurodegenerative diseases as well as lysosomal disorders. Prevail Therapeutics focuses on leveraging the latest breakthroughs in human genetics for potential disease-modifying targets in neurodegenerative conditions, targeting patient populations with urgent unmet needs (currently, there are no available therapies to alter the progression of these diseases). By studying the company’s gene therapies in genetically defined patient groups, Prevail applies a precision medicine approach to neurodegeneration.